Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Annika Malmström"'
Autor:
Małgorzata Łysiak, Małgorzata Trybuła, Munila Mudaisi, Charlotte Bratthäll, Michael Strandeus, Peter Milos, Martin Hallbeck, Annika Malmström
Publikováno v:
Molecular Oncology, Vol 16, Iss 19, Pp 3436-3451 (2022)
We sought to analyse the androgen receptor (AR) in glioblastoma (GBM) due to the location of the AR gene on chromosome X, often reported with shorter survival and higher prevalence of GBM among males. Copy number (CN) and mRNA expression of AR were t
Externí odkaz:
https://doaj.org/article/337ccc57f9014fe9b50c382e783dedc5
Autor:
Pierre Bady, Christine Marosi, Michael Weller, Bjørn H. Grønberg, Henrik Schultz, Martin J. B. Taphoorn, Johanna M. M. Gijtenbeek, Martin J. van den Bent, Andreas von Deimling, Roger Stupp, Annika Malmström, Monika E. Hegi
Publikováno v:
Acta Neuropathologica Communications, Vol 10, Iss 1, Pp 1-18 (2022)
Abstract Elderly patients represent a growing proportion of individuals with glioblastoma, who however, are often excluded from clinical trials owing to poor expected prognosis. We aimed at identifying age-related molecular differences that would jus
Externí odkaz:
https://doaj.org/article/f25d671f678e412283b2b0a390e01828
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Patients with glioblastoma (GBM) have a poor outcome, but even among patients receiving the same therapies and with good prognostic factors, one can find those with exceptionally short and long survival. From the Nordic trial, which randomized GBM pa
Externí odkaz:
https://doaj.org/article/db210b32c5b94ad8ac9191159e0e5b5c
Patients with glioblastoma (GBM) have a short survival, but even among patients receiving the same therapies and with good prognostic factors, one can find those with exceptionally short and long survival.In the Nordic trial, patients with GBM, 60 ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8048b18295df84a88f495553ac30b6d8
https://doi.org/10.1101/2022.02.21.22271286
https://doi.org/10.1101/2022.02.21.22271286
Autor:
Annika Malmström, Lisa Åkesson, Peter Milos, Marit Karlsson, Helena Bruhn, M Mudaisi, Michael Strandeus
Publikováno v:
Supportive Care in Cancer
Purpose Glioma patients have poor prognosis. The amount of detail of disease-related information patients wish to receive is not known. The aim of this study was to explore glioma patients’ experiences and preferences regarding receiving informatio
Autor:
Roger Henriksson, Annika Malmström, Peter Milos, Ida Blystad, Helena Bruhn, Charlotte Dahle, Jonas Lind, Magnus Vrethem
Objectives Seizures as presenting symptom of glioblastoma (GBM) are known to predict prolonged survival, whereas the clinical impact of other initial symptoms is less known. Our main objective was to evaluate the influence of different presenting sym
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::384c6dc9e79b35bb2e6ed3d237bba72e
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-179431
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-179431
Autor:
Björn Tavelin, Annika Malmström
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 3; Pages: 486
Journal of Clinical Medicine, Vol 11, Iss 486, p 486 (2022)
Journal of Clinical Medicine, Vol 11, Iss 486, p 486 (2022)
Sex disparities in glioblastoma (GBM) have received increasing attention. Sex-related differences for several molecular markers have been reported, which could impact on clinical factors and outcomes. We therefore analyzed data on all patients with G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b58a6b68cd12e1d42ec554aeca1bdbf6
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-183062
http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-183062
Autor:
Wolfgang Wick, Corneel Coens, Martin J. van den Bent, Thierry Gorlia, Andrea Talacchi, Neil K. Aaronson, Annika Malmström, Martin J B Taphoorn, Olivier Chinot, Jaap C. Reijneveld, Brigitta G. Baumert, Andrew Bottomley, Alba A. Brandes, Ulrich Herrlinger, Francesca Martinelli, Roger Stupp, Linda Dirven, Florence Keime-Guibert, Marijke B. Coomans, Michael Weller
Publikováno v:
European Journal of Cancer, 116, 190-198. Pergamon
European Journal of Cancer, 116, 190-198. Elsevier Ltd.
EORTC Quality of Life Group and the EORTC Brain Tumor Group 2019, ' The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients : a meta-analysis based on individual patient data from randomised controlled trials ', European Journal of Cancer, vol. 116, pp. 190-198 . https://doi.org/10.1016/j.ejca.2019.05.012
European Journal of Cancer, 116, 190-198. ELSEVIER SCI LTD
European Journal of Cancer, 116, 190-198
European Journal of Cancer, 116, 190-198. Elsevier
European Journal of Cancer, 116, 190-198. Elsevier Ltd.
EORTC Quality of Life Group and the EORTC Brain Tumor Group 2019, ' The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients : a meta-analysis based on individual patient data from randomised controlled trials ', European Journal of Cancer, vol. 116, pp. 190-198 . https://doi.org/10.1016/j.ejca.2019.05.012
European Journal of Cancer, 116, 190-198. ELSEVIER SCI LTD
European Journal of Cancer, 116, 190-198
European Journal of Cancer, 116, 190-198. Elsevier
Objective: Prognostic value of health-related quality of life (HRQoL) data may be important to inform patients in clinical practice and to guide clinical decision-making. Our study investigated the added prognostic value of HRQoL for overall survival
Autor:
Anna Dimberg, M Mudaisi, Peter Milos, Peter Söderkvist, Anja Smits, Elisabeth Sandberg, Kenney Roy Roodakker, Michael Strandeus, Charlotte Bratthäll, Annika Malmström, Małgorzata Łysiak, Martin Hallbeck
Publikováno v:
Cancers
Cancers, Vol 13, Iss 1619, p 1619 (2021)
Volume 13
Issue 7
Cancers, Vol 13, Iss 1619, p 1619 (2021)
Volume 13
Issue 7
Simple Summary Glioblastoma (GBM) is one of the most common and most aggressive brain tumors with higher prevalence among men than women. Loss of chromosome Y (LOY) in the peripheral blood cells has been associated with increased risk of developing c
Autor:
Roger Stupp, Neil K. Aaronson, Annika Malmström, Florence Keime-Guibert, W. Wick, Jaap C. Reijneveld, Andrew Bottomley, Francesca Martinelli, Corneel Coens, Ulrich Herrlinger, Andrea Talacchi, Marijke B. Coomans, M. J. van den Bent, B. Baumert, Thierry Gorlia, Linda Dirven, A. A. Brandes, Martin J B Taphoorn, O Chinot
Publikováno v:
Neuro-Oncology. 23:ii2-ii3
BACKGROUND Maintenance of functioning and wellbeing during the progression-free survival (PFS) period is important for glioma patients. This study aimed to determine whether health-related quality of life (HRQoL) can be maintained during progression-